These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 15969928)

  • 1. The influence of Surelease and sodium alginate on the in-vitro release of tamsulosin hydrochloride in pellet dosage form.
    Kim MS; Jun SW; Lee S; Lee TW; Park JS; Hwang SJ
    J Pharm Pharmacol; 2005 Jun; 57(6):735-42. PubMed ID: 15969928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of sodium alginate on physical and dissolution properties of Surelease-matrix pellets prepared by a novel pelletizer.
    Kim MS; Kim JS; Hwang SJ
    Chem Pharm Bull (Tokyo); 2007 Nov; 55(11):1631-4. PubMed ID: 17978525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of water soluble additives and HPMCP on drug release from Surelease-coated pellets containing tamsulosin hydrochloride.
    Kim MS; Kim JS; Kang SH; Yoo YH; Lee S; Park JS; Woo JS; Hwang SJ
    Arch Pharm Res; 2007 Aug; 30(8):1008-13. PubMed ID: 17879755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pectin/Ethylcellulose as film coatings for colon-specific drug delivery: preparation and in vitro evaluation using 5-fluorouracil pellets.
    Wei H; Qing D; De-Ying C; Bai X; Fanli-Fang
    PDA J Pharm Sci Technol; 2007; 61(2):121-30. PubMed ID: 17479720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of drug release from pellets coated with HPMC or Surelease.
    Sadeghi F; Ford JL; Rubinstein MH; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2000 Jun; 26(6):651-60. PubMed ID: 10826113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alginate-based pellets prepared by extrusion/spheronization: effect of the amount and type of sodium alginate and calcium salts.
    Sriamornsak P; Nunthanid J; Luangtana-anan M; Weerapol Y; Puttipipatkhachorn S
    Eur J Pharm Biopharm; 2008 May; 69(1):274-84. PubMed ID: 17962003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a tamsulosin hydrochloride controlled-release capsule consisting of two different coated pellets.
    Zhang X; Tang X; Yang R
    Drug Dev Ind Pharm; 2009 Jan; 35(1):26-33. PubMed ID: 18686088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of in situ dispersible and calcium cross-linked alginate pellets as intestinal-specific drug carrier by melt pelletization technique.
    Nurulaini H; Wong TW
    J Pharm Sci; 2011 Jun; 100(6):2248-57. PubMed ID: 21213311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of chitosan type on the properties of extruded pellets with low amount of microcrystalline cellulose.
    Charoenthai N; Kleinebudde P; Puttipipatkhachorn S
    AAPS PharmSciTech; 2007 Aug; 8(3):E64. PubMed ID: 17915814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of tamsulosin hydrochloride controlled release pellets coated with Surelease and neutralized HPMCP.
    Kim MS; Kim JS; Lee S; Jun SW; Park JS; Woo JS; Hwang SJ
    J Pharm Pharmacol; 2006 Dec; 58(12):1611-6. PubMed ID: 17331324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of drug type on the release profiles from Surelease-coated pellets.
    Sadeghi F; Ford JL; Rajabi-Siahboomi A
    Int J Pharm; 2003 Mar; 254(2):123-35. PubMed ID: 12623188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastro-resistant characteristics of GRAS-grade enteric coatings for pharmaceutical and nutraceutical products.
    Czarnocka JK; Alhnan MA
    Int J Pharm; 2015; 486(1-2):167-74. PubMed ID: 25796126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of chitosan and sodium alginate and formulation variables on the formation and drug release from pellets prepared by extrusion/spheronisation.
    Chatchawalsaisin J; Podczeck F; Newton JM
    Int J Pharm; 2004 May; 275(1-2):41-60. PubMed ID: 15081137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-emulsifying excipient platform for improving technological properties of alginate-hydroxypropylcellulose pellets.
    Mannina P; Segale L; Giovannelli L; Bonda AF; Pattarino F
    Int J Pharm; 2016 Feb; 499(1-2):74-80. PubMed ID: 26721727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of drug release from pellets coated with Surelease containing hydroxypropylmethylcellulose.
    Sadeghi F; Ford JL; Rubinstein MH; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2001 May; 27(5):419-30. PubMed ID: 11448049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coatless alginate pellets as sustained-release drug carrier for inflammatory bowel disease treatment.
    Md Ramli SH; Wong TW; Naharudin I; Bose A
    Carbohydr Polym; 2016 Nov; 152():370-381. PubMed ID: 27516284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled release tamsulosin hydrochloride from alginate beads with waxy materials.
    Kim MS; Park GD; Jun SW; Lee S; Park JS; Hwang SJ
    J Pharm Pharmacol; 2005 Dec; 57(12):1521-8. PubMed ID: 16354396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Entrapment of andrographolide in cross-linked alginate pellets: I. Formulation and evaluation of associated release kinetics.
    Shariff A; PK M; KLK P; M M
    Pak J Pharm Sci; 2007 Jan; 20(1):1-9. PubMed ID: 17337420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of the release mechanism of Theophylline from pellets coated with Surelease
    Kazlauske J; Cafaro MM; Caccavo D; Marucci M; Lamberti G; Barba AA; Larsson A
    Int J Pharm; 2017 Aug; 528(1-2):345-353. PubMed ID: 28583332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug release, preclinical and clinical pharmacokinetics relationships of alginate pellets prepared by melt technology.
    Bose A; Harjoh N; Pal TK; Dan S; Wong TW
    Expert Opin Drug Deliv; 2016; 13(1):143-54. PubMed ID: 26307229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.